Clear Perspective Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$216K Sell
2,980
-360
-11% -$24.8K 0.07% 167
2021
Q3
$233K Buy
+3,340
New +$235K 0.08% 153
2021
Q1
Sell
-7,068
Closed -$412K 154
2020
Q4
$412K Buy
7,068
+597
+9% +$36K 0.17% 100
2020
Q3
$2.38K Buy
6,471
+1,550
+31% +$107K 1.12% 17
2020
Q2
$379K Buy
+4,921
New +$377K 0.21% 84
2020
Q1
Sell
-4,597
Closed -$318K 71
2019
Q4
$299K Sell
4,597
-1,391
-23% -$90.6K 0.19% 107
2019
Q3
$380K Sell
5,988
-1,400
-19% -$91.5K 0.17% 97
2019
Q2
$499K Sell
7,388
-3,149
-30% -$207K 0.32% 76
2019
Q1
$680K Buy
10,537
+1,857
+21% +$123K 0.48% 55
2018
Q4
$543K Buy
8,680
+300
+4% +$21K 0.45% 69
2018
Q3
$647K Hold
8,380
0.48% 64
2018
Q2
$594K Buy
8,380
+1,525
+22% +$108K 0.42% 70
2018
Q1
$517K Buy
6,855
+1,000
+17% +$79.5K 0.39% 75
2017
Q4
$419K Buy
5,855
+235
+4% +$17.8K 0.32% 83
2017
Q3
$455K Buy
5,620
+300
+6% +$22.9K 0.37% 75
2017
Q2
$377K Hold
5,320
0.32% 81
2017
Q1
$361K Buy
5,320
+2,200
+71% +$155K 0.24% 85
2016
Q4
$223K Buy
+3,120
New +$232K 0.15% 119

Other funds holding GILD

Clear Perspective Advisors's GILD Position: Q4 2021 in Review

Clear Perspective Advisors reduced its Gilead Sciences (GILD) stake by 11% in Q4 2021, selling an estimated $24.8K and leaving 2,980 shares worth $216K. The position accounts for 0.07% of the portfolio, ranked #167.

Clear Perspective Advisors first reported a position in GILD in Q4 2016 and has held it in 18 quarters since. The position peaked at $680K in Q1 2019. 1,683 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Clear Perspective Advisors held 2,980 shares of Gilead Sciences worth $216K as of Q4 2021.
  • Clear Perspective Advisors sold 360 Gilead Sciences shares in Q4 2021, an estimated $24.8K.
  • Gilead Sciences made up 0.07% of Clear Perspective Advisors's portfolio in Q4 2021, its #167 holding.
  • Clear Perspective Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 18 quarters since.
  • Clear Perspective Advisors's Gilead Sciences position peaked at $680K in Q1 2019.
  • 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Clear Perspective Advisors's 13F filing for Q4 2021, filed 17 Feb 2022.